CD19 and lymphoma: CD19-directed CAR-T cells were generated from young and old CD8+ T cells (CD45.1+) and were adoptively transferred into mice (CD45.2+) engrafted with EL4 lymphoma cancer cells overexpressing mouse CD19 (mCD19) (Fig. 4l).